Prediction models for progression from diabetic kidney disease to end-stage renal disease: a systematic review and meta-analysis - Report - MDSpire

Prediction models for progression from diabetic kidney disease to end-stage renal disease: a systematic review and meta-analysis

  • By

  • Yang Shi

  • Zhaoxi Dong

  • Xiaomeng Shan

  • Xiqian Wang

  • Siyu Huang

  • Hongfang Liu

  • Linqi Zhang

  • May 20, 2026

  • 0 min

Share

Clinical Report: Systematic Review and Meta-Analysis of DKD to ESRD Models

Overview

This systematic review and meta-analysis evaluates prediction models for progression from diabetic kidney disease (DKD) to end-stage renal disease (ESRD). Despite promising discrimination in training and validation cohorts, significant methodological limitations and high risk of bias restrict the clinical applicability of these models.

Background

Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease (ESRD), necessitating effective risk prediction models for early identification of patients at high risk of progression. The increasing prevalence of diabetes and its complications underscores the importance of developing reliable predictive tools to guide clinical decision-making and resource allocation. This review addresses a critical gap in the literature by focusing on models predicting the transition from established DKD to ESRD.

Data Highlights

Model TypePooled AUC95% CI
Training Models0.8960.853–0.940
Validation Models0.8630.803–0.923

Key Findings

  • Fifteen studies were included, all assessed at high risk of bias.
  • Pooled AUCs for training models were 0.896, indicating good discrimination.
  • Pooled AUCs for validation models were 0.863, also indicating satisfactory performance.
  • Methodological limitations included retrospective designs and inadequate external validation.
  • Subgroup analyses showed no significant differences based on pathological predictors or prediction horizon.
  • Future studies should focus on prospective multicenter designs with rigorous validation.

Clinical Implications

Clinicians should be cautious when applying existing DKD to ESRD prediction models due to their high risk of bias and methodological limitations. There is a pressing need for robust, externally validated models to improve risk stratification and patient management in clinical practice.

Conclusion

While current models show potential for predicting progression from DKD to ESRD, their clinical utility is limited by significant methodological flaws. Future research must prioritize rigorous validation to enhance the reliability of these predictive tools.

Related Resources & Content

  1. Frontiers | Prediction models for progression from diabetic kidney disease to end-stage renal disease: a systematic review and meta-analysis
  2. npj Digital Medicine — Risk Prediction of Chronic Kidney Disease Progression in Type 2 Diabetes Mellitus Across Diverse Populations
  3. The Journal of Clinical Endocrinology & Metabolism — A New Predictive Model for Kidney Failure in Chronic Kidney Disease Patients: The Role of Serum Bilirubin Concentrations
  4. Frontiers in Endocrinology — A Transparent Machine Learning Approach Utilizing Standard Metabolic Lab Indices for Detecting Advanced Chronic Kidney Disease
  5. Creation and assessment of a prognostic model for renal function one year post simultaneous pancreas and kidney transplantation utilizing pre-transplant donor and recipient factors
  6. KDIGO 2024 CKD Guideline
  7. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy | New England Journal of Medicine
  8. Frontiers | Prediction models for progression from diabetic kidney disease to end-stage renal disease: a systematic review and meta-analysis

Original Source(s)

Related Content